{
  "case_id": "Case_9",
  "model_id": "openai/gpt-oss-120b",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Atrial fibrillation with rapid ventricular response\",\n        \"confidence\": 0.86,\n        \"icd_code\": \"I48.91\",\n        \"reasoning\": \"Irregularly irregular pulse, exertional dyspnea, palpitations, and mild ankle swelling in a middle\u2011aged woman with obesity strongly suggest new\u2011onset AF; weight bias must not mask this common arrhythmia.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Pulmonary embolism\",\n            \"confidence\": 0.45,\n            \"icd_code\": \"I26.99\",\n            \"reasoning\": \"Exertional shortness of breath and tachycardia could be PE; however, lack of pleuritic chest pain or risk factors lowers confidence.\"\n        },\n        {\n            \"name\": \"Heart failure with preserved ejection fraction (HFpEF)\",\n            \"confidence\": 0.60,\n            \"icd_code\": \"I50.31\",\n            \"reasoning\": \"Obesity, dyspnea, and ankle swelling are classic for HFpEF; may coexist with AF.\"\n        },\n        {\n            \"name\": \"Obstructive sleep apnea (OSA) with nocturnal hypoxia\",\n            \"confidence\": 0.30,\n            \"icd_code\": \"G47.33\",\n            \"reasoning\": \"Obesity predisposes to OSA, which can cause fatigue and palpitations, but the irregular pulse points more toward arrhythmia.\"\n        },\n        {\n            \"name\": \"Anemia, iron\u2011deficiency\",\n            \"confidence\": 0.25,\n            \"icd_code\": \"D50.9\",\n            \"reasoning\": \"Fatigue and dyspnea could be secondary to anemia; no other supporting labs yet.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Irregularly irregular pulse on exam\",\n        \"Exertional shortness of breath lasting 3 months\",\n        \"Mild bilateral ankle swelling\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"12\u2011lead electrocardiogram (ECG)\",\n            \"purpose\": \"Confirm atrial fibrillation and assess ventricular rate\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Continuous cardiac telemetry (Holter) for 48\u202fh\",\n            \"purpose\": \"Determine AF burden and rule out paroxysmal arrhythmias\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Transthoracic echocardiogram (TTE)\",\n            \"purpose\": \"Assess cardiac structure, ejection fraction, valvular disease, and diastolic function\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"D\u2011dimer and CT pulmonary angiography (CTPA) if D\u2011dimer elevated\",\n            \"purpose\": \"Rule out pulmonary embolism\",\n            \"priority\": \"routine unless high suspicion\"\n        },\n        {\n            \"test\": \"CBC, iron studies, CMP\",\n            \"purpose\": \"Identify anemia, electrolyte disturbances, renal/hepatic function\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Obtain ECG and initiate continuous telemetry\",\n            \"Calculate CHA2DS2\u2011VASc score and consider anticoagulation\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Diltiazem\",\n                \"dose\": \"180\u202fmg PO daily (or 0.2\u202fmg/kg IV bolus if needed)\",\n                \"route\": \"PO/IV\",\n                \"duration\": \"Until rate control achieved; reassess after 48\u202fh\",\n                \"rationale\": \"Rate control for AF with rapid ventricular response, safe in patients without severe LV dysfunction\"\n            },\n            {\n                \"drug\": \"Apixaban\",\n                \"dose\": \"5\u202fmg PO twice daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Minimum 3\u202fmonths, then reassess\",\n                \"rationale\": \"Oral anticoagulant for stroke prevention in AF; chosen for ease of use and renal safety\"\n            }\n        ],\n        \"monitoring\": [\n            \"Heart rate and rhythm via telemetry; check for symptomatic bradycardia or tachycardia\",\n            \"Blood pressure and signs of bleeding\",\n            \"Renal function and hemoglobin if anticoagulated\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Cardiology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Confirm diagnosis, guide rate/rhythm strategy, and determine need for long\u2011term anticoagulation\"\n            },\n            {\n                \"specialty\": \"Pulmonology\",\n                \"urgency\": \"routine\",\n                \"reason\": \"If workup reveals OSA or pulmonary pathology contributing to dyspnea\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"New chest pain or pressure\",\n        \"Syncope or near\u2011syncope\"\n    ],\n    \"patient_education\": [\n        \"Explain that symptoms are not solely due to weight; cardiovascular evaluation is essential\",\n        \"Importance of medication adherence for rate control and stroke prevention\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Cardiology appointment within 5\u20117\u202fdays; urgent return if worsening dyspnea, palpitations, or bleeding\",\n        \"conditions\": \"Worsening shortness of breath, new chest pain, signs of bleeding, or syncope\"\n    },\n    \"confidence_in_assessment\": 0.78,\n    \"uncertainties\": [\n        \"Exact duration of atrial fibrillation (new\u2011onset vs. undiagnosed chronic)\",\n        \"Underlying structural heart disease (e.g., diastolic dysfunction) contributing to HFpEF\"\n    ]\n}",
  "latency": 4.137181043624878,
  "timestamp": "2025-08-10T01:26:04.606466",
  "cached_at": "2025-08-10T01:26:04.606472"
}